The briefing
The Pharmaceutical Journal summarizes recent studies on semaglutide’s impact on liver health, vaccine responses in people with obesity, and emerging avenues for treating pancreatic cancer. The roundup highlights early evidence and potential clinical implications for practice.
Original headline
Health news round-up: semaglutide and liver health, obesity vaccine response and hope for pancreatic cancer